Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · Journal of Clinical Oncology · 2009 · 2.1K citations · Full text

Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

Robert C. Flanigan, Sydney E. Salmon, Brent A. Blumenstein et al. · New England Journal of Medicine · 2001 · 1.7K citations

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

GHJ Mickisch, A. Garin, Hendrik Van Poppel et al. · The Lancet · 2001 · 1.4K citations

Urology, Surgical Oncology, Interferon-alfa-based Immunotherapy +8

Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Jennifer Bacik, Lawrence H. Schwartz et al. · Journal of Clinical Oncology · 2004 · 800 citations

Sarcomatoid Differentiation in Renal Cell Carcinoma

Mariza de Peralta‐Venturina, Holger Moch, Mitual Amin et al. · The American Journal of Surgical Pathology · 2001 · 501 citations